A Standardized Onion Peel-Derived Bioactive Ingredient Attenuates Palmitate-Induced Steatosis and Oxidative Stress by Modulating Mitochondrial Dynamics and Autophagy in HepG2 Cells
Abstract
1. Introduction
2. Materials and Methods
2.1. Reagents and Materials
2.2. Preparation and Standardization of the Onion Peel Ingredient (OPI-T)
2.3. Chemical Standardization and Quality Specifications of OPI-T
2.4. UHPLC–UV–HRMS/MS Analysis
2.5. Experimental Design
2.6. Preparation of Palmitate Solutions
2.7. Cell Viability MTT Assay
2.8. Wound Healing (Scratch) Assay for Cell Migration Analysis
2.9. Oil Red O Staining
2.10. BODIPY Fluorescence Probe Staining for Microscopy
2.11. Intracellular ROS Measurement by DCFH-DA Assay
2.12. Western Blotting Analysis
2.13. Statistical Analysis
3. Results
3.1. UHPLC–UV–HRMS/MS Profiling of OPI-T and Comparative Onion Peel Extracts
3.2. OPI-T Does Not Significantly Affect HepG2 Cell Viability at Functionally Relevant Concentrations
3.3. OPI-T Mildly Modulates HepG2 Cell Migration Without Inducing Excessive Antiproliferative Effects
3.4. OPI-T Attenuates Palmitate-Induced Lipid Accumulation in HepG2 Cells
3.5. OPI-T Markedly Reduces Palmitate-Induced Oxidative Stress in HepG2 Cells
3.6. OPI-T Modulates Mitochondrial Dynamics by Restoring the Fusion–Fission Balance Under Palmitate-Induced Stress
3.7. OPI-T Modulates Autophagy-Related Markers in Palmitate-Treated HepG2 Cells
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Wei, S.; Wang, L.; Evans, P.C.; Xu, S. NAFLD and NASH: Etiology, targets and emerging therapies. Drug Discov. Today 2024, 29, 103910. [Google Scholar] [CrossRef] [PubMed]
- Karlsen, T.H.; Rutter, H.; Carrieri, P.; Zelber-Sagi, S.; Engebretsen, E.; Hutchinson, S.; Voigt, K.; Guha, N.; Berzigotti, A.; Schomerus, G.; et al. The EASL-Lancet Commission on liver health in Europe: Prevention, case-finding, and early diagnosis to reduce liver-related mortality. Lancet 2024, 403, 1522–1524. [Google Scholar] [CrossRef] [PubMed]
- Jurek, J.M.; Zablocka-Sowinska, K.; Clavero Mestres, H.; Reyes Gutiérrez, L.; Camaron, J.; Auguet, T. The impact of dietary interventions on metabolic outcomes in metabolic dysfunction-associated steatotic liver disease (MASLD) and comorbid conditions, including obesity and type 2 diabetes. Nutrients 2025, 17, 1257. [Google Scholar] [CrossRef]
- Armandi, A.; Bugianesi, E. Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease. Eur. J. Intern. Med. 2024, 122, 20–27. [Google Scholar] [CrossRef]
- Dungubat, E.; Fujikura, K.; Kuroda, M.; Fukusato, T.; Takahashi, Y. Food nutrients and bioactive compounds for managing metabolic dysfunction-associated steatotic liver disease: A comprehensive review. Nutrients 2025, 17, 2211. [Google Scholar] [CrossRef]
- Ye, Q.; Yuan, S.; Cai, D. Synergistic potential of natural products and exercise: Unveiling molecular mechanisms and innovative therapeutic approaches for liver diseases. Front. Nutr. 2025, 12, 1656048. [Google Scholar] [CrossRef]
- Campone, L.; Celano, R.; Piccinelli, A.L.; Pagano, I.; Carabetta, S.; Di Sanzo, R.; Russo, M.; Ibañez, E.; Cifuentes, A.; Rastrelli, L. Response surface methodology to optimize supercritical carbon dioxide/co-solvent extraction of brown onion skin by-product as source of nutraceutical compounds. Food Chem. 2018, 269, 495–502. [Google Scholar] [CrossRef]
- Celano, R.; Docimo, T.; Piccinelli, A.L.; Gazzerro, P.; Tucci, M.; Di Sanzo, R.; Carabetta, S.; Campone, L.; Russo, M.; Rastrelli, L. Onion Peel: Turning a Food Waste into a Resource. Antioxidants 2021, 10, 304. [Google Scholar] [CrossRef]
- Fromenty, B.; Roden, M. Mitochondrial alterations in fatty liver diseases. J. Hepatol. 2023, 78, 415–429. [Google Scholar] [CrossRef]
- Teixeira, F.S.; Pimentel, L.L.; Vidigal, S.S.M.P.; Azevedo-Silva, J.; Pintado, M.E.; Rodríguez-Alcalá, L.M. Differential Lipid Accumulation on HepG2 Cells Triggered by Palmitic and Linoleic Fatty Acids Exposure. Molecules 2023, 28, 2367. [Google Scholar] [CrossRef]
- Malik, S.; Inamdar, S.; Acharya, J.; Goel, P.; Ghaskadbi, S. Characterization of palmitic acid toxicity induced insulin resistance in HepG2 cells. Toxicol. Vitr. 2024, 97, 105802. [Google Scholar] [CrossRef] [PubMed]
- Xin, S.L.; Pan, X.L.; Xu, X.Y.; Yu, Y.Y. USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells. J. Clin. Transl. Hepatol. 2023, 11, 45–57. [Google Scholar] [CrossRef]
- Li, W.; Cai, Z.; Schindler, F.; Afjehi-Sadat, L.; Montsch, B.; Heffeter, P.; Heiss, E.H.; Weckwerth, W. Elevated PINK1/Parkin-Dependent Mitophagy and Boosted Mitochondrial Function Mediate Protection of HepG2 Cells from Excess Palmitic Acid by Hesperetin. J. Agric. Food Chem. 2024, 72, 13039–13053. [Google Scholar] [CrossRef]
- Oh, S.J.; Hwang, Y.; Hur, K.Y.; Lee, M.-S. Lysosomal Ca2+ as a mediator of palmitate-induced lipotoxicity. Cell Death Discov. 2023, 9, 100. [Google Scholar] [CrossRef] [PubMed]
- Rafiei, H.; Ormidian, K.M.; Bandy, B. Protection by different classes of dietary polyphenols against palmitic acid-induced steatosis, nitro-oxidative stress and endoplasmic reticulum stress in HepG2 hepatocytes. J. Funct. Foods 2018, 44, 173–182. [Google Scholar] [CrossRef]
- Kanuri, G.; Bergheim, I. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). Int. J. Mol. Sci. 2013, 14, 11963–11980. [Google Scholar] [CrossRef]
- Zheng, X.; Zhao, M.G.; Jiang, C.H.; Sheng, X.P.; Yang, H.M.; Liu, Y.; Yao, X.M.; Zhang, J.; Yin, Z.Q. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway. Phytomedicine 2020, 66, 153130. [Google Scholar] [CrossRef] [PubMed]
- Gai, H.; Zhou, F.; Zhang, Y.; Ai, J.; Zhan, J.; You, Y.; Huang, W. Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway. J. Food Sci. 2020, 85, 4050–4060. [Google Scholar] [CrossRef]
- Srnic, N.; Westcott, F.; Caney, E.; Hodson, L. Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans. Dis. Model. Mech. 2025, 18, dmm050878. [Google Scholar] [CrossRef]
- Du, J.; Wang, T.; Xiao, C.; Dong, Y.; Zhou, S.; Zhu, Y. Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Hepatic Steatosis In vitro. Curr. Mol. Med. 2024, 24, 1506–1517. [Google Scholar] [CrossRef]
- Luo, L.; Wu, Q.; Xiao, Q.; Chen, Y.; Deng, Z.; Cen, C.; Lin, J. Lipotoxicity-induced upregulation of FIS1 exacerbates mitochondrial fragmentation and promotes NLRP3-dependent pyroptosis in diabetic cardiomyopathy. Free Radic. Biol. Med. 2025, 228, 183–196. [Google Scholar] [CrossRef]
- Sharafi, F.; Rismani, E.; Rhmanian, M.; Khosravi, A.; Zarrabi, A.; Vosough, M. Mitochondrial dysfunction in hepatocellular carcinoma: From metabolism to targeted therapies. Mol. Cell Biochem. 2025, 480, 6015–6038. [Google Scholar] [CrossRef] [PubMed]
- Zeng, W.; Wang, L.; Wang, C.; Xiong, X.; Huang, Q.; Chen, S.; Liu, C.; Liu, W.; Wang, Y.; Huang, Q. SENP1 prevents high fat diet-induced non-alcoholic fatty liver diseases by regulating mitochondrial dynamics. Biochim. Biophys. Acta Mol. Basis Dis. 2025, 1871, 167527. [Google Scholar] [CrossRef] [PubMed]
- Wang, S.; Long, H.; Hou, L.; Feng, B.; Ma, Z.; Wu, Y.; Zeng, Y.; Cai, J.; Zhang, D.W.; Zhao, G. The mitophagy pathway and its implications in human diseases. Signal Transduct. Target. Ther. 2023, 8, 304. [Google Scholar] [CrossRef] [PubMed]
- Zeng, J.; Acin-Perez, R.; Assali, E.A.; Martin, A.; Brownstein, A.J.; Petcherski, A.; Fernández-Del-Rio, L.; Xiao, R.; Lo, C.H.; Shum, M.; et al. Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nat. Commun. 2023, 14, 2573. [Google Scholar] [CrossRef]
- Kim, B.S.; Kim, H.J.; Kim, H.; Lee, J.; Ahn, S.B.; Shin, J.H.; Lim, Y.H. Hepatic Steatosis in Cardiovascular–Kidney–Metabolic Syndrome: Fatty Liver Index as a Predictor of Cardiovascular Outcomes. Eur. J. Prev. Cardiol. 2025, zwaf396. [Google Scholar] [CrossRef]
- Wang, H.; Luo, W.; Chen, H.; Cai, Z.; Xu, G. Mitochondrial dynamics and mitochondrial autophagy: Molecular structure, orchestrating mechanism and related disorders. Mitochondrion 2024, 75, 101847. [Google Scholar] [CrossRef]
- Arzumanian, V.A.; Kiseleva, O.I.; Poverennaya, E.V. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. Int. J. Mol. Sci. 2021, 22, 13135. [Google Scholar] [CrossRef]
- Ma, L.; Lu, Q.Y.; Lim, S.; Han, G.; Boros, L.G.; Desai, M.; Yee, J.K. The Effect of Flavonoids and Topiramate on Glucose Carbon Metabolism in a HepG2 Steatosis Cell Culture Model: A Stable Isotope Study. Nutrients 2025, 17, 564. [Google Scholar] [CrossRef]
- Li, T.; Wang, W.; Zhu, M.; Dong, T.; Jiang, J.; Li, Z.; An, T.; Chen, X.; Mao, Y.; Chen, Y.; et al. The antineoplastic effects of nuciferine on hepatocellular carcinoma are associated with suppression of the HER2-AKT/ERK1/2 signaling pathway. Discov. Oncol. 2025, 16, 822. [Google Scholar] [CrossRef]
- Nabih, H.K.; Hamed, A.R.; Yahya, S.M.M. Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition. Sci. Rep. 2023, 13, 4396. [Google Scholar] [CrossRef]
- Rafiei, H.; Omidian, K.; Bandy, B. Comparison of Dietary Polyphenols for Protection against Molecular Mechanisms Underlying Nonalcoholic Fatty Liver Disease in a Cell Model of Steatosis. Mol. Nutr. Food Res. 2017, 61, 1600781. [Google Scholar] [CrossRef]
- Liu, Y.; Liao, L.; Chen, Y.; Han, F. Effects of Daphnetin on Lipid Metabolism, Insulin Resistance and Oxidative Stress in Oa-Treated Hepg2 Cells. Mol. Med. Rep. 2019, 19, 4673–4684. [Google Scholar] [CrossRef]
- Lei, Y.; Ma, X.L.; Liu, T.; Wang, M.J.; Kang, J.S.; Yang, J.; Mi, N. Lactucin ameliorates FFA-induced steatosis in HepG2 cells by modulating mitochondrial homeostasis through the SIRT1/PGC-1α signaling axis. Heliyon 2024, 10, e39890. [Google Scholar] [CrossRef]
- Aibaidula, Y.; Aimaiti, M.; Tan, H.; Chen, B.; Yang, J.; Ma, X. Lactucin & Lactucopicrin ameliorates FFA-induced steatosis in HepG2 cells via modulating lipid metabolism. J. Pharmacol. Sci. 2022, 150, 110–122. [Google Scholar] [CrossRef]
- Soret, P.A.; Magusto, J.; Housset, C.; Gautheron, J. In vitro and in vivo models of non-alcoholic fatty liver disease: A critical appraisal. J. Clin. Med. 2020, 10, 36. [Google Scholar] [CrossRef]
- Zhao, L.; Yang, L.; Ahmad, K. Kaempferol ameliorates palmitate-induced lipid accumulation in HepG2 cells through activation of the Nrf2 signaling pathway. Hum. Exp. Toxicol. 2023, 42, 9603271221146780. [Google Scholar] [CrossRef]
- Song, S.; Zhao, W.; Lin, Q.; Pei, J.; Jin, H. Peptides from Harpadon nehereus bone ameliorate sodium palmitate-induced HepG2 lipotoxicity by regulating oxidative stress and lipid metabolism. Mar. Drugs 2025, 23, 118. [Google Scholar] [CrossRef]
- Ling, Y.; Wang, W.; Li, X.; Wang, X.; Zhang, S.; Huang, S.; Zhou, H.; Peng, L.; Yin, W. Rosa roxburghii Tratt fruit extract ameliorate free fatty acid induced steatosis in HepG2 cells through activating PI3K-Akt and PPAR pathways. Sci. Rep. 2025, 15, 26169. [Google Scholar] [CrossRef]
- de Sousa, I.F.; Migliaccio, V.; Lepretti, M.; Paolella, G.; Di Gregorio, I.; Caputo, I.; Ribeiro, E.B.; Lionetti, L. Dose-and time-dependent effects of oleate on mitochondrial fusion/fission proteins and cell viability in HepG2 cells: Comparison with palmitate effects. Int. J. Mol. Sci. 2021, 22, 9812. [Google Scholar] [CrossRef]
- Dhami-Shah, H.; Vaidya, R.; Udipi, S.; Raghavan, S.; Abhijit, S.; Mohan, V.; Balasubramanyam, M.; Vaidya, A. Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis. Clin. Mol. Hepatol. 2018, 24, 77–87. [Google Scholar] [CrossRef] [PubMed]
- Qiu, B.; Simon, M.C. BODIPY 493/503 Staining of Neutral Lipid Droplets for Microscopy and Quantification by Flow Cytometry. Bio Protoc. 2016, 6, e1912. [Google Scholar] [CrossRef] [PubMed]
- Chen, Q.; Lou, Y. G protein-coupled receptor 39 alleviates mitochondrial dysfunction and hepatocyte lipid accumulation via SIRT1/Nrf2 signaling. J. Bioenerg. Biomembr. 2023, 55, 33–42. [Google Scholar] [CrossRef] [PubMed]
- Uttarawichien, T.; Khumsri, W.; Suwannalert, P.; Sibmooh, N.; Payuhakrit, W. Onion peel extract inhibits cancer cell growth and progression through the roles of L1CAM, NF-κB, and angiogenesis in HT-29 colorectal cancer cells. Prev. Nutr. Food Sci. 2021, 26, 330–337. [Google Scholar] [CrossRef]
- Zhang, L.; Seitz, L.C.; Abramczyk, A.M.; Chan, C. Synergistic effect of cAMP and palmitate in promoting altered mitochondrial function and cell death in HepG2 cells. Exp. Cell Res. 2010, 316, 716–727. [Google Scholar] [CrossRef]
- Sundaram, S.; Bishnu, D.; Santra, S.; Purkait, S.; Dey, D.; Mukherjee, P.S.; Dhali, G.; Chowdhury, A.; Santra, A. Involvement of lysosomal dysfunction and its association with lipotoxic stress in palmitate-treated HepG2 cells. Cureus 2026, 18, e103064. [Google Scholar] [CrossRef]
- Kim, Y.J.; Lee, J.R.; Kim, M.R.; Jeong, J.A.; Kim, J.J.; Jeong, K.W. Protein kinase-mediated inhibition of autophagy by palmitic acid in hepatocytes. Eur. J. Pharmacol. 2025, 998, 177528. [Google Scholar] [CrossRef]
- Zhao, Y.; Li, J.; Ma, A.; Wang, Z.; Ni, Y.; Wu, D.; Zhou, Y.; Zhang, N.; Zhang, L.; Chang, Y.; et al. Irisin alleviates hepatic steatosis by activating the autophagic SIRT3 pathway. Chin Med. J. 2026, 139, 443–456. [Google Scholar] [CrossRef]
- Afshari, H.; Noori, S.; Zarghi, A. A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway. Naunyn Schmiedeberg’s Arch. Pharmacol. 2023, 396, 3135–3148. [Google Scholar] [CrossRef]
- Chu, Q.; Zhang, S.; Chen, M.; Han, W.; Jia, R.; Chen, W.; Zheng, X. Cherry Anthocyanins Regulate NAFLD by Promoting Autophagy Pathway. Oxidative Med. Cell. Longev. 2019, 2019, 4825949. [Google Scholar] [CrossRef]
- Li, D.; Cui, Y.; Wang, X.; Liu, F.; Li, X. Apple polyphenol extract alleviates lipid accumulation in free-fatty-acid-exposed HepG2 cells via activating autophagy mediated by SIRT1/AMPK signaling. Phytother. Res. 2021, 35, 1416–1431. [Google Scholar] [CrossRef]
- Sa-Ngiamsuntorn, K.; Rojsanga, P.; Ruenraroengsak, P.; Jaturanpinyo, M.; Petchprayoon, C.; Bunsupa, S.; Satitpatipan, V.; Pewkliang, Y.; Thongsri, P.; Sithisarn, P. Hepatoprotective effects of Acanthopanax trifoliatus standardized leaf extract and its formulations in a HepG2 model. BMC Complement. Med. Ther. 2025, 25, 319. [Google Scholar] [CrossRef] [PubMed]
- Sharma, S.; Sharma, A.; Gupta, P.; Arora, D.; Deswal, G.; Grewal, A.; Sharma, D. The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis. Cardiovasc. Hematol. Disord. Drug Targets 2025, 25, 168–192. [Google Scholar] [CrossRef] [PubMed]
- Gonfa, Y.H.; Bachheti, A.; Semwal, P.; Rai, N.; Singab, A.N.; Bachheti, R.K. Hepatoprotective activity of medicinal plants, their phytochemistry, and safety concerns: A systematic review. Z. Naturforschung C J. Biosci. 2024, 80, 61–73. [Google Scholar] [CrossRef] [PubMed]
- Yousefi-Manesh, H.; Dehpour, A.R.; Ansari-Nasab, S.; Hemmati, S.; Sadeghi, M.A.; Shahraki, R.H.; Shirooie, S.; Nabavi, S.M.; Nkuimi Wandjou, J.G.; Sut, S.; et al. Hepatoprotective Effects of Standardized Extracts from an Ancient Italian Apple Variety (Mela Rosa dei Monti Sibillini) against Carbon Tetrachloride (CCl4)-Induced Hepatotoxicity in Rats. Molecules 2020, 25, 1816. [Google Scholar] [CrossRef]
- Shareef, S.H.; Ibrahim, I.A.A.; Alzahrani, A.R.; Al-Medhtiy, M.H.; Abdulla, M.A. Hepatoprotective effects of methanolic extract of green tea against Thioacetamide-Induced liver injury in Sprague Dawley rats. Saudi J. Biol. Sci. 2022, 29, 564–573. [Google Scholar] [CrossRef]
- Elhassaneen, Y.A.; Nasef, A.Z.; Arafa, R.S.; Bayomi, A.I. Bioactive compounds and antioxidant activities of milk thistle (Silybum marianum) extract and their potential roles in the prevention of diet-induced obesity complications. Am. J. Food Sci. Tech. 2023, 11, 70–85. [Google Scholar] [CrossRef]
- Mohib, M.; Afnan, K.; Paran, T.Z.; Khan, S.; Sarker, J.; Hasan, N.; Hasan, I.; Sagor, A.T. Beneficial Role of Citrus Fruit Polyphenols Against Hepatic Dysfunctions: A Review. J. Diet. Suppl. 2018, 15, 223–250. [Google Scholar] [CrossRef]
- Chang, J.; Huang, C.; Li, S.; Jiang, X.; Chang, H.; Li, M. Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis. Molecules 2023, 29, 127. [Google Scholar] [CrossRef]
- Danieli, A.; Vucak, G.; Baccarini, M.; Martens, S. Sequestration of translation initiation factors in p62 condensates. Cell Rep. 2023, 42, 113583. [Google Scholar] [CrossRef]
- Hasnat, H.; Shompa, S.A.; Islam, M.M.; Alam, S.; Richi, F.T.; Emon, N.U.; Ashrafi, S.; Ahmed, N.U.; Chowdhury, M.N.R.; Fatema, N.; et al. Flavonoids: A treasure house of prospective pharmacological potentials. Heliyon 2024, 10, e27533. [Google Scholar] [CrossRef]
- Chandrasekaran, V.; Hediyal, T.A.; Anand, N.; Kendaganna, P.H.; Gorantla, V.R.; Mahalakshmi, A.M.; Ghanekar, R.K.; Yang, J.; Sakharkar, M.K.; Chidambaram, S.B. Polyphenols, autophagy and neurodegenerative diseases: A review. Biomolecules 2023, 13, 1196. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Zhao, W.; Sair, A.T.; Li, T.; Liu, R.H. Ferulic acid restores mitochondrial dynamics and autophagy via AMPK signaling pathway in a palmitate-induced hepatocyte model of metabolic syndrome. Sci. Rep. 2024, 14, 18970. [Google Scholar] [CrossRef] [PubMed]
- Itakura, E.; Mizushima, N. p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J. Cell Biol. 2011, 192, 17–27. [Google Scholar] [CrossRef] [PubMed]
- Lu, J.; Meng, Z.; Chen, Y.; Yu, L.; Gao, B.; Zheng, Y.; Guan, S. Apigenin induced autophagy and stimulated autophagic lipid degradation. Food Funct. 2020, 11, 9208–9215. [Google Scholar] [CrossRef]
- Kim, H.S.; Montana, V.; Jang, H.J.; Parpura, V.; Kim, J.A. Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: A potential role for reducing lipid accumulation. J. Biol. Chem. 2013, 288, 22693–22705. [Google Scholar] [CrossRef]
- Peng, H.; Cheng, Q.; Chen, J.; Wang, Y.; Du, M.; Lin, X.; Zhao, Q.; Chen, S.; Zhang, J.; Wang, X. Green Tea Epigallocatechin-3-gallate Ameliorates Lipid Accumulation and Obesity-Associated Metabolic Syndrome via Regulating Autophagy and Lipolysis in Preadipocytes and Adipose Tissue. J. Agric. Food Chem. 2025, 73, 12272–12291. [Google Scholar] [CrossRef]
- Katsaros, I.; Sotiropoulou, M.; Vailas, M.; Papachristou, F.; Papakyriakopoulou, P.; Grigoriou, M.; Kostomitsopoulos, N.; Giatromanolaki, A.; Valsami, G.; Tsaroucha, A.; et al. The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study. Nutrients 2024, 16, 4282. [Google Scholar] [CrossRef]
- Yu, J.; Fu, R.; Buhe, A.; Xu, B. Quercetin attenuates lipopolysaccharide-induced hepatic inflammation by modulating autophagy and necroptosis. Poult. Sci. 2024, 103, 103719. [Google Scholar] [CrossRef]
- Cao, P.; Wang, Y.; Zhang, C.; Sullivan, M.A.; Chen, W.; Jing, X.; Yu, H.; Li, F.; Wang, Q.; Zhou, Z.; et al. Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy. J. Nutr. Biochem. 2023, 120, 109414. [Google Scholar] [CrossRef]
- Meng, Z.; Han, Y.; Ruan, L.; Xu, C.; Zhang, M.; Liu, H. Establishment and evaluation of HepG2 cell insulin resistance model. Diabetes Metab. Syndr. Obes. 2025, 18, 2573–2584. [Google Scholar] [CrossRef]








| [M − H]− (m/z) | [M + H]+ (m/z) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N° | Compound | Molecular Formula | RT(UV) (min) | Measured (m/z) | Error (ppm) | Product Ion MS/MS | Measured (m/z) | Error (ppm) | Product Ion MS/MS | Onion |
| 1 | Protocatechuic acid | C7H6O4 | 1.0 | 153.1234 | 0.9 | / | / | / | / | M, T |
| 2 | 2-(3,4-Dihydroxybenzoyl)-2,4,6-trihydroxy-3(2H)-benzofuranone | C15H10O8 | 6.0 | 317.0302 | 1.2 | 299; 191; 207; 273 | / | / | / | M, T |
| 3 | Cyanidin 3-glucoside | C21H21O11 | 6.5 | / | / | / | 449.1076 | −0.7 | 287 | T |
| 4 | Quercetin dihexoside | C27H30O17 | 7.0 | 625.1402 | 0.7 | 463; 301 | 627.1524 | 0.8 | 465; 303 | M, T |
| 5 | Cyanidin 3-laminaribioside | C27H31O16 | 6.7 | / | / | / | 611.1611 | 0.8 | 287 | T |
| 6 | Quercetin 3,4′-diglucoside | C27H30O17 | 7.4 | 625.1411 | 0.4 | 463; 301 | 627.1533 | 3.2 | 465; 303 | M, T |
| 7 | Isorhamnetin dihexoside | C28H32O17 | 7.9 | 639.1570 | 0.03 | 477; 315 | 641.1688 | 3.6 | 317; 479 | M, T |
| 8 | Cyanidin 3-malonilglucoside | C24H23O14 | 8.1 | / | / | / | 535.1085 | 0.6 | 287 | T |
| 9 | Cyanidin 3-malonillaminaribioside | C30H33O19 | 8.6 | / | / | / | 697.1605 | 0.7 | 287 | T |
| 10 | Quercetin-3-glucoside | C21H20O12 | 8.9 | 463.0873 | 0.6 | 301 | 465.1004 | 3.4 | 303 | M, T |
| 11 | Quercetin-4′-glucoside | C21H20O12 | 11.1 | 463.0872 | 0.6 | 301 | 465.1005 | 3.9 | 303 | M, T |
| 12 | Isorhamnetin-O-hexoside | C22H22O12 | 12.7 | 477.1030 | 0.6 | 315 | 479.1160 | 4.3 | 317 | M, T |
| 13 | Quercetin | C15H10O7 | 14.1 | 301.0351 | 0.9 | 179; 151 | 303.0486 | 3.6 | 285; 257; 229; | M, T |
| 14 | Protocatecoyl quercetin | C22H14O11 | 14.8 | 453.0452 | 0.3 | 299 | 455.5880 | −4.3 | 437; 301; | M, T |
| 15 | Protocatecoyl quercetin | C22H14O11 | 14.9 | 453.0452 | 0.6 | 299 | 455.0589 | −4.6 | 437; 301; | M, T |
| 16 | Kaempferol | C15H10O6 | 16.9 | 285.0399 | 2.1 | / | 287.0535 | −4.9 | / | M, T |
| 17 | Isorhamnetin | C16H12O7 | 17.2 | 315.0501 | 0.8 | 300; 257 | 317.0640 | −3.4 | 302, 285; 257 | M, T |
| 18 | Quercetin dimer 4′-glucoside | C36H28O19 | 17.7 | 763.1142 | 0.4 | 611; 449; | 765.1259 | −4.4 | 603; 451 | M, T |
| 19 | Quercetin dimer 4′-glucoside | C36H28O19 | 18.8 | 763.1140 | 0.5 | 611; 600; 299 | 765.1255 | −4.2 | 603; 585 | M, T |
| 20 | Quercetin dimer hexoside | C36H28O19 | 19.1 | 763.1140 | 0.5 | 611; 600; 299 | 765.1265 | −4.3 | 603; 585 | M, T |
| 21 | Quercetin dimer | C30 H18 O14 | 20.0 | 601.0615 | 0.9 | 449; 299 | 603.0733 | −5.1 | 585; 313; 303 | M, T |
| 22 | Quercetin trimer | C45 H26 O21 | 21.3 | 901.0880 | −0.4 | 299; 449; 599; 601 | 903.0233 | −4.9 | 885; 751; 585; 613 | M, T |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Di Gregorio, I.; Migliaccio, V.; D’Elia, M.; Celano, R.; Santoro, V.; Piccinelli, A.L.; Russo, M.; Rastrelli, L.; Lionetti, L. A Standardized Onion Peel-Derived Bioactive Ingredient Attenuates Palmitate-Induced Steatosis and Oxidative Stress by Modulating Mitochondrial Dynamics and Autophagy in HepG2 Cells. Antioxidants 2026, 15, 513. https://doi.org/10.3390/antiox15040513
Di Gregorio I, Migliaccio V, D’Elia M, Celano R, Santoro V, Piccinelli AL, Russo M, Rastrelli L, Lionetti L. A Standardized Onion Peel-Derived Bioactive Ingredient Attenuates Palmitate-Induced Steatosis and Oxidative Stress by Modulating Mitochondrial Dynamics and Autophagy in HepG2 Cells. Antioxidants. 2026; 15(4):513. https://doi.org/10.3390/antiox15040513
Chicago/Turabian StyleDi Gregorio, Ilaria, Vincenzo Migliaccio, Maria D’Elia, Rita Celano, Valentina Santoro, Anna Lisa Piccinelli, Mariateresa Russo, Luca Rastrelli, and Lillà Lionetti. 2026. "A Standardized Onion Peel-Derived Bioactive Ingredient Attenuates Palmitate-Induced Steatosis and Oxidative Stress by Modulating Mitochondrial Dynamics and Autophagy in HepG2 Cells" Antioxidants 15, no. 4: 513. https://doi.org/10.3390/antiox15040513
APA StyleDi Gregorio, I., Migliaccio, V., D’Elia, M., Celano, R., Santoro, V., Piccinelli, A. L., Russo, M., Rastrelli, L., & Lionetti, L. (2026). A Standardized Onion Peel-Derived Bioactive Ingredient Attenuates Palmitate-Induced Steatosis and Oxidative Stress by Modulating Mitochondrial Dynamics and Autophagy in HepG2 Cells. Antioxidants, 15(4), 513. https://doi.org/10.3390/antiox15040513

